CD317 is over-expressed in B-cell chronic lymphocytic leukemia, but not B-cell acute lymphoblastic leukemia.
- 1 February 2015
- journal article
- Vol. 8 (2) , 1613-21
Abstract
CD317 was first identified as a multiple myeloma-associated antigen. Here we report the expression of CD317 in normal B cells and B-cell malignancies. In normal bone marrow, CD317 demonstrates a biphasic expression pattern, with higher expression on stage 1 and stage 3 hematogones, but not on stage 2 hematogones. CD317 is over-expressed in B-cell chronic lymphocytic leukemia, and appears associated with negative CD38 expression. Moreover, CD317 is barely detectable in B-cell acute lymphoblastic leukemia. Our results suggest that CD317 expression might be of prognostic significance for B-CLL, and CD317 could be used as a new marker for minimal residual disease detection in B-ALL.Keywords
This publication has 37 references indexed in Scilit:
- Identification of Alternatively Translated Tetherin Isoforms with Differing Antiviral and Signaling ActivitiesPLOS Pathogens, 2012
- Tetherin is a key effector of the antiretroviral activity of type I interferon in vitro and in vivoProceedings of the National Academy of Sciences, 2011
- In vivo expression profile of the antiviral restriction factor and tumor-targeting antigen CD317/BST-2/HM1.24/tetherin in humansProceedings of the National Academy of Sciences, 2011
- Regulation of TLR7/9 responses in plasmacytoid dendritic cells by BST2 and ILT7 receptor interactionJournal of Experimental Medicine, 2009
- Up-regulation of bone marrow stromal protein 2 (BST2) in breast cancer with bone metastasisBMC Cancer, 2009
- Inhibition of Lassa and Marburg Virus Production by TetherinJournal of Virology, 2009
- Vpu enhances HIV-1 virus release in the absence of Bst-2 cell surface down-modulation and intracellular depletionProceedings of the National Academy of Sciences, 2009
- Tetherin-mediated restriction of filovirus budding is antagonized by the Ebola glycoproteinProceedings of the National Academy of Sciences, 2009
- Broad-Spectrum Inhibition of Retroviral and Filoviral Particle Release by TetherinJournal of Virology, 2009
- Molecular Cloning and Characterization of a Surface Antigen Preferentially Overexpressed on Multiple Myeloma CellsBiochemical and Biophysical Research Communications, 1999